摘要
背景:老龄化是人类生活的一个自然部分。然而,最近的发现表明,用于改善和可能延缓衰老过程的药理学方法可能为这一主题提供了新的线索。这显然有助于延长老年人的积极生活和维持他们的生活质量,从而可以减少每个国家,特别是发达国家的社会和经济负担。 目的:本研究的目的是探索可能有助于延缓或改善衰老过程的药理学发现。更具体地说,作者着眼于三种抗衰老药物候选物:二甲双胍,雷帕霉素和白藜芦醇,以及一种抗动脉粥样硬化成分NAD +前体,其动物随机对照试验似乎在这方面提供了一些效果,并且它们似乎在人类的衰老过程。 方法:通过对可用来源进行文献回顾来描述衰老过程问题,特别关注那些抗衰老候选药物。 结果:该研究的结果表明有希望的抗衰老候选物似乎是二甲双胍,特别是就心血管或癌症死亡率而言,以及NAD +前体,因为它们似乎促进更好的器官功能,增加的身体抵抗力,抗病性和延长预期寿命。 结论:需要更多的纵向临床试验,这将证明有希望的抗衰老药物候选人在人体中的功效。
关键词: 抗衰老候选药物,白藜芦醇,二甲双胍,雷帕霉素,NAD +,sirtuin。
Current Medicinal Chemistry
Title:Anti-Aging Drugs – Prospect of Longer Life?
Volume: 25 Issue: 17
关键词: 抗衰老候选药物,白藜芦醇,二甲双胍,雷帕霉素,NAD +,sirtuin。
摘要: Background: Aging is a natural part of human life. However, recent discoveries indicate that pharmacological approaches used for the improvement and possibly, for the delay of the aging process, might shed a new light on this topic. This might obviously contribute to the extension of the active life of older people and maintenance of their quality of life, which could consequently reduce both social and economic burden of each country, especially the developed ones.
Objective: The purpose of this study is to explore pharmacological discoveries which may help to the delay or improvement of the aging process. More specifically, the authors focus on three anti-aging drugs candidates: metformin, rapamycin and resveratrol and one anti-aging component NAD+ precursors whose randomized control trials on animals have appeared to provide some efficacy in this respect and they seem to be promising in the aging process of human beings.
Methods: This was done by conducting a literature review of available sources describing the issue of aging process with special focus on those anti-aging drug candidates.
Results: The results of this study indicate that promising anti-aging candidates seem to be metformin, especially as far as cardiovascular or cancer mortality is concerned, and NAD+ precursors since they appear to promote better organ function, increased physical resistance, disease resistance and prolonged life expectancy.
Conclusion: There is a call for more longitudinal clinical trials, which would prove the efficacy of the promising anti-aging drugs candidates in humans.
Export Options
About this article
Cite this article as:
Anti-Aging Drugs – Prospect of Longer Life?, Current Medicinal Chemistry 2018; 25 (17) . https://dx.doi.org/10.2174/0929867325666171129215251
DOI https://dx.doi.org/10.2174/0929867325666171129215251 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sex-Related Differences in Polygraphic Parameters in a Population of
Patients with Obstructive Sleep Apnea Syndrome
CNS & Neurological Disorders - Drug Targets Oral Hypoglycemics: A Review of Chemicals Used to Treat Type 2 Diabetes
Current Bioactive Compounds Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease
Current Pharmaceutical Design Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining
Current Topics in Medicinal Chemistry Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Current Medicinal Chemistry Phosphodiesterase 3 (PDE3): Structure, Localization and Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelin Receptors in Gastrointestinal Smooth Muscle
Current Protein & Peptide Science Recent Advances and Patents on Novel Devices for Minimally Invasive Treatment of Functional Mitral Regurgitation
Recent Patents on Biomedical Engineering (Discontinued) Synthesis and Preliminary Antihyperlipidaemic Activities Evaluation of Andrographolide Derivatives
Medicinal Chemistry Designing and Testing New Therapeutic Modalities for Treatment of Inflammatory Bowel Disease: Role of Experimental Animal Models
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Vascular Endothelial Dysfunction
Current Drug Targets Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design The CRF Receptor Structure, Function and Potential for Therapeutic Intervention.
Current Medicinal Chemistry - Central Nervous System Agents Oral Insulin: Myth or Reality
Current Diabetes Reviews Therapeutic Potential of Co-enzyme Q10 in Retinal Diseases
Current Medicinal Chemistry New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma
Current Medicinal Chemistry Deletion of Endoplasmic Reticulum Stress-Induced CHOP Protects Microvasculature Post-Spinal Cord Injury
Current Neurovascular Research Natural Alkaloids and Diabetes Mellitus: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Caldesmon as a Therapeutic Target for Proliferative Vascular Diseases
Mini-Reviews in Medicinal Chemistry Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel
Current Topics in Medicinal Chemistry